tiprankstipranks
AstraZeneca Pharma India Limited (IN:ASTRAZEN)
:ASTRAZEN
India Market
ASTRAZEN
AstraZeneca Pharma India Limited
RESEARCH TOOLSreports
Want to see IN:ASTRAZEN full AI Analyst Report?

AstraZeneca Pharma India Limited (ASTRAZEN) Income Statement

33 Followers

AstraZeneca Pharma India Limited Income Statement

Last quarter (Q2 2026), AstraZeneca Pharma India Limited's total revenue was ₹5.59B, an increase of 37.03% from the same quarter last year. In Q2, AstraZeneca Pharma India Limited's net income was ₹542.20M. See AstraZeneca Pharma India Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 25Mar 24Mar 23Mar 22Mar 21
Total Revenue
₹ 17.13B₹ 12.96B₹ 10.03B₹ 8.06B₹ 8.09B
Gross Profit
₹ 7.13B₹ 6.22B₹ 5.78B₹ 4.48B₹ 4.78B
Operating Expenses
₹ 4.98B₹ 4.51B₹ 4.29B₹ 3.78B₹ 3.62B
Depreciation and Amortization
₹ 399.90M₹ 149.40M₹ 162.60M₹ 169.50M₹ 197.50M
EBITDA
₹ 1.98B₹ 2.36B₹ 1.51B₹ 1.01B₹ 1.48B
Operating Income
₹ 2.15B₹ 1.71B₹ 1.49B₹ 696.50M₹ 1.16B
Other Income/Expenses
₹ -584.50M₹ 481.10M₹ -147.90M₹ 133.90M₹ 108.30M
Pretax Income
₹ 1.56B₹ 2.20B₹ 1.34B₹ 830.40M₹ 1.27B
Net Income
₹ 1.16B₹ 1.62B₹ 992.90M₹ 616.00M₹ 933.00M
Per Share Metrics
Basic EPS
₹ 46.30₹ 64.60₹ 39.72₹ 24.64₹ 37.32
Diluted EPS
₹ 46.30₹ 64.60₹ 39.72₹ 24.64₹ 37.32
Weighted Average Shares Outstanding
 25.00M 25.00M 25.00M 25.00M 25.00M
Weighted Average Shares Outstanding (Diluted)
 25.00M 25.00M 25.00M 25.00M 25.00M
Currency in INR

AstraZeneca Pharma India Limited Earnings and Revenue History